FDA Approved: FYCOMPA — Supplemental Application (Eisai Inc.)

View source ↗

Summary

The FDA approved Eisai's supplemental application for FYCOMPA (perampanel), resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Tonic-clonic Seizures
• Partial-onset Seizures

Drugs mentioned

• Fycompa (perampanel)

Snippet

SUPPL AP for FYCOMPA (PERAMPANEL)